JP2012510438A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012510438A5 JP2012510438A5 JP2011537906A JP2011537906A JP2012510438A5 JP 2012510438 A5 JP2012510438 A5 JP 2012510438A5 JP 2011537906 A JP2011537906 A JP 2011537906A JP 2011537906 A JP2011537906 A JP 2011537906A JP 2012510438 A5 JP2012510438 A5 JP 2012510438A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- lipophilic component
- surfactant
- insulin peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08170231.8 | 2008-11-28 | ||
| EP08170231 | 2008-11-28 | ||
| PCT/EP2009/053017 WO2009115469A1 (en) | 2008-03-18 | 2009-03-13 | Protease stabilized, acylated insulin analogues |
| EPPCT/EP2009/053017 | 2009-03-13 | ||
| PCT/EP2009/062126 WO2010060667A1 (en) | 2008-11-28 | 2009-09-18 | Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012510438A JP2012510438A (ja) | 2012-05-10 |
| JP2012510438A5 true JP2012510438A5 (cg-RX-API-DMAC7.html) | 2012-09-20 |
Family
ID=40524842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011537906A Withdrawn JP2012510438A (ja) | 2008-11-28 | 2009-09-18 | 誘導体化インスリンペプチドの経口投与に適した医薬組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20110293714A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2370059A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2012510438A (cg-RX-API-DMAC7.html) |
| CN (1) | CN102227213A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010060667A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2514406A1 (en) * | 2007-06-01 | 2012-10-24 | Novo Nordisk A/S | Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier |
| AU2008257505B2 (en) * | 2007-06-01 | 2013-05-16 | Novo Nordisk A/S | Stable non-aqueous pharmaceutical compositions |
| HUE032284T2 (en) | 2008-03-18 | 2017-09-28 | Novo Nordisk As | Protease-stabilized, acylated insulin analogues |
| BR112012016853A2 (pt) * | 2010-01-12 | 2017-10-17 | Novo Nordisk As | "composições farmacêuticas para administração oral de peptídeos de insulina". |
| WO2012006956A1 (zh) | 2010-07-14 | 2012-01-19 | 中国医学科学院药物研究所 | 一种胰岛素的脂质复合物及其制备方法和制剂 |
| JP2013540771A (ja) | 2010-10-15 | 2013-11-07 | ノヴォ ノルディスク アー/エス | 新規n末端修飾インスリン誘導体 |
| CN103458873B (zh) * | 2011-04-14 | 2016-04-13 | 诺沃—诺迪斯克有限公司 | 用于口服肽递送的脂肪酸酰化的氨基酸 |
| WO2013093009A1 (en) | 2011-12-21 | 2013-06-27 | Novo Nordisk A/S | N -terminally modified insulin derivatives |
| EA023447B1 (ru) * | 2011-12-28 | 2016-06-30 | Борис Славинович ФАРБЕР | Производное инсулина, обладающее сахароснижающей активностью при пероральном применении, способ его получения и лекарственные формы на его основе |
| WO2013128003A1 (en) | 2012-03-01 | 2013-09-06 | Novo Nordisk A/S | N-terminally modified oligopeptides and uses thereof |
| EP2836508B1 (en) | 2012-04-11 | 2016-06-29 | Novo Nordisk A/S | Insulin formulations |
| JP6285447B2 (ja) * | 2012-10-17 | 2018-02-28 | ノヴォ ノルディスク アー/エス | 経口ペプチド送達用の脂肪酸アシル化d−アミノ酸 |
| CN103405753B (zh) * | 2013-08-13 | 2016-05-11 | 上海仁会生物制药股份有限公司 | 稳定的促胰岛素分泌肽水针药物组合物 |
| US20160113906A1 (en) * | 2014-09-19 | 2016-04-28 | Board Of Regents, The University Of Texas System | Methods of preparing extrudates |
| EP3215128B1 (en) | 2014-11-04 | 2019-09-04 | Innopharmax, Inc. | Oral administration of unstable or poorly-absorbed drugs |
| ES2886837T3 (es) | 2016-12-16 | 2021-12-21 | Novo Nordisk As | Composiciones farmacéuticas que contienen insulina |
| EP3768094B1 (en) | 2018-03-15 | 2024-05-01 | R.P. Scherer Technologies, LLC | Enteric softgel capsules |
| MY210034A (en) * | 2019-03-15 | 2025-08-22 | Novo Nordisk As | Process for spray drying a glp-1 peptide |
| JP7778509B2 (ja) * | 2021-09-24 | 2025-12-02 | 株式会社 資生堂 | 化粧料 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4839341A (en) * | 1984-05-29 | 1989-06-13 | Eli Lilly And Company | Stabilized insulin formulations |
| US5206219A (en) * | 1991-11-25 | 1993-04-27 | Applied Analytical Industries, Inc. | Oral compositions of proteinaceous medicaments |
| US7060675B2 (en) * | 2001-02-15 | 2006-06-13 | Nobex Corporation | Methods of treating diabetes mellitus |
| US20070292523A1 (en) * | 2004-09-27 | 2007-12-20 | Joey Moodley | Dihydropyrimidine Formulations |
| EP2514406A1 (en) * | 2007-06-01 | 2012-10-24 | Novo Nordisk A/S | Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier |
| WO2009022006A1 (en) * | 2007-08-15 | 2009-02-19 | Novo Nordisk A/S | Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids |
-
2009
- 2009-09-18 CN CN2009801475240A patent/CN102227213A/zh active Pending
- 2009-09-18 EP EP09783181A patent/EP2370059A1/en not_active Withdrawn
- 2009-09-18 US US13/131,608 patent/US20110293714A1/en not_active Abandoned
- 2009-09-18 WO PCT/EP2009/062126 patent/WO2010060667A1/en not_active Ceased
- 2009-09-18 JP JP2011537906A patent/JP2012510438A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2012133075A (ru) | Фармацевтическая композиция для перорального введения инсулиновых пептидов | |
| NZ596657A (en) | Self micro-emulsifying oral pharmaceutical composition of hydrophilic drug and preparation method thereof | |
| AR045490A1 (es) | Glucopiranosiloxi - pirazoles, medicamentos que contienen estos compuestos, su uso y procedimiento para su preparacion | |
| WO2013043841A8 (en) | Cleaning formulations with improved surfactant solubility and methods of production and use thereof | |
| JP6320442B2 (ja) | エレクトロウェッティング素子及び流体 | |
| UA102477C2 (en) | Capsule composition | |
| NZ590496A (en) | Hard surface cleaning composition | |
| AR045906A1 (es) | Composicion farmaceutica para mejorar la solubilidad de farmacos hidrofobicos | |
| AR073880A1 (es) | Un compuesto heterociclico, composicion farmaceutica que lo compone y metodos para inhibir la proteasa ns3/ns4 y para incrementar la funcion hepatica con dichos compuesto y metodo para tratar fibrosis hepatica con los mismos. | |
| AR071533A1 (es) | Microemulsion mejorada con un amplio rango de aplicacion | |
| GB0218002D0 (en) | Pharmaceutical compositions | |
| RU2016114537A (ru) | Композиции антагонистов рецепторов cgrp | |
| NZ603699A (en) | Injectable parasiticidal formulations of levamisole and macrocyclic lactones | |
| WO2008099835A1 (ja) | Peg充填硬質カプセル剤のバンドシール | |
| AR054778A1 (es) | Uso de sangliferina en hcv | |
| CA2600023A1 (en) | Solvent system for enhancing the solubility of pharmaceutical agents | |
| JP2013528838A5 (cg-RX-API-DMAC7.html) | ||
| ES2786749T3 (es) | Composición farmacéutica para administración oral que comprende una concentración elevada de taxano | |
| BR112014003103B1 (pt) | composição de limpeza, método para remover uma sujidade graxa e método para fazer um limpador de superfície desengraxante | |
| RU2011101688A (ru) | Сосуд для медицинских препаратов и способ его изготовления | |
| JP2009242356A (ja) | 洗浄料 | |
| RU2006100112A (ru) | Трансназальные микроэмульсии, содержащие диазепам | |
| KR101612259B1 (ko) | 고농도의 탁산을 포함하는 경구 투여용 약학 조성물 | |
| NL2028762B1 (en) | Micelle-generating formulations for enhanced bioavailability | |
| EP3326652B1 (en) | Pharmaceutical composition for oral administration comprising high concentration taxane |